Title
Urging the United States' Federal Trade Commission (FTC) to delay the merger of the Rite Aid Corporation with Walgreens Boots Alliance until the impact of the merger is fully disclosed to the Citizens of Philadelphia.
Body
WHEREAS, The Rite Aid Corporation is the nation's leading drugstore chain and the largest drugstore chain on the East Coast. Rite Aid employs roughly 89,000 associates and employs an estimated 2,350 people in Central Pennsylvania; and
WHEREAS, Rite Aid strives to be a sustaining community pharmacy that can better meet the growing demand for affordable, high-quality health services. Its mission is to improve the health and wellness of our communities through engaging in experiences that provide its customers with the best products, services and advice to meet their unique needs; and
WHEREAS, In 2014, Rite Aid released its model RediClinic that provides the community with high-quality, affordable, and convenient healthcare. The RediClinic board-certified clinicians collaborate with local physicians to treat common medical conditions and provide preventive care on a walk-in basis, seven days a week. RediClinic treats more than 30 conditions and also provides affordable alternative health screenings, medical tests immunizations, and physical exams; and
WHEREAS, Over the years, Rite Aid has required their pharmacists to provide care beyond prescriptions and meet the growing demand for convenient, high-quality health services. In Fiscal 2016, Rite Aid's 11,000 pharmacists nationwide administered 3.9 million immunizations, facilitated additional pharmacists -patient consultations through the new "Quit for You" smoking cessation program, and launched the Vaccine Central, a comprehensive set of online and in-store tools that promote the availability and importance of all vaccinations to citizens of various communities across the United States; and
WHEREAS, According to the National Association of Chain Drug Stores (NACDS) the ...
Click here for full text